Rubicon Research IPO 2025 1377 Crore Offering Opens Today
Rubicon Research Limited a Mumbai based pharmaceutical company has launched its Initial Public Offering today aiming to raise 1377 crore rupees. The IPO comprises a fresh issue of 500 crore rupees and an offer for sale of 877.5 crore rupees.
IPO Details
Price Band: 461 to 485 rupees per share
Issue Size: 1377 crore rupees
Retail Lot Size: 30 shares (14550 rupees at upper price band)
Subscription Dates: October 9 to October 13 2025
Listing Date: October 16 2025
Anchor Investors: Raised 619.08 crore rupees from 38 investors
LG Electronics IPO GMP Today: Grey Market Premium & Listing Outlook 2025
Financial Highlights
Revenue Growth: 82 percent annual growth from FY23 to FY25
EBIT and Net Profit: Turned positive after FY23 losses
Gross Margins: Approximately 70 percent
Return on Net Worth: 29 percent
Risks to Consider
Revenue Concentration: 98 percent from the US market
Client Concentration: 71 percent from top five clients
Regulatory Risks: Exposure to US tariffs and policy changes
Titan Share Price Today: Live Update & Analysis 2025
Should You Subscribe
Investors with a high risk appetite may consider subscribing for long term gains given Rubicon Research strong financials and growth prospects. However it is important to consider the concentration risks and market dependencies.
Useful Links
Official IPO Prospectus: Rubicon Research
Subscription Status and Updates: IPO Watch
Brokerage Reviews and GMP: Financial Express
Stay informed and make an educated investment decision